Related Experiment Videos
Encapsulated, genetically modified cells producing in vivo therapeutics
Oliver Hauser1, Eva Prieschl-Grassauer, Brian Salmons
1Research Institute for Virology and Biomedicine, University of Veterinary Medicine, Veterinaerplatz 1, A-1210 Vienna, Austria.
Current Opinion in Molecular Therapeutics
|October 8, 2004
Summary
Encapsulating genetically modified cells in immunoprotective materials shows therapeutic promise. This review covers polymers for cell encapsulation and their use in treating diseases, discussing challenges and solutions.
Area of Science:
- Biomaterials Science
- Cell Therapy
- Immunology
Background:
- Genetically modified cells offer therapeutic potential but face immune rejection.
- Cell encapsulation in immuno-isolating materials can prevent immune responses.
- This technique has applications in treating various diseases.
Purpose of the Study:
- To review polymer types for cell encapsulation.
- To discuss the use of encapsulated, genetically modified cells in disease treatment.
- To identify challenges and solutions in immunoprotection technologies.
Main Methods:
- Literature review of polymer materials for cell encapsulation.
- Analysis of studies using encapsulated cells in animal models and clinical trials.
- Discussion of technological challenges and proposed solutions.
Main Results:
- Various polymers are suitable for cell encapsulation, offering immunoprotection.
- Encapsulated genetically modified cells have shown efficacy in preclinical and clinical studies.
- Key challenges include material biocompatibility, cell survival, and long-term function.
Conclusions:
- Polymer-based immuno-isolation of genetically modified cells is a promising therapeutic strategy.
- Further research is needed to overcome existing challenges for clinical translation.
- This technology holds potential for treating a range of diseases effectively.